Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.14 -0.01 (-0.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acurx Pharmaceuticals (ACXP) Change in Receivables (2024 - 2026)

Updated

Acurx Pharmaceuticals (ACXP) reported Change in Receivables of $38,994 for Q2 2026, down 3.0% from $40,208 a year earlier but up 393.8% from the prior quarter.

Analysis

Acurx Pharmaceuticals (ACXP) Change in Receivables (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Acurx Pharmaceuticals' Change in Receivables came in at $55,099; for FY2025, it was -$2,710.

  • By year, Change in Receivables came in at -$78,032 in FY2024 and $129,159 in FY2023.
  • Five-year quarterly Change in Receivables spans a low of -$129,159 in Q1 2024 and a high of $51,127 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Acurx Pharmaceuticals 4.86 Mn -28.61 Mn - 38,994.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38,994.00
Mar 31, 2026 7,896.00
Dec 31, 2025 8,209.00
Jun 30, 2025 40,208.00
Mar 31, 2025 -51,127.00
Dec 31, 2024 -46,246.00
Sep 30, 2024 46,246.00
Jun 30, 2024 51,127.00
Mar 31, 2024 -129,159.00
API Access

Acurx Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ACXP&period=max&api_key=YOUR_API_KEY